Jochen B Fiebach Selected Research

Jochen B Fiebach Research Topics

Disease

65	Stroke (Strokes) 01/2022 - 01/2006
44	Ischemic Stroke 01/2022 - 02/2003
9	Atrial Fibrillation 01/2022 - 07/2010
5	Infarction (Infarctions) 01/2020 - 10/2013
5	Hemorrhage 01/2019 - 03/2006
4	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2021 - 12/2016
4	Cerebral Hemorrhage 04/2018 - 02/2007
3	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 01/2016
3	Ischemia 01/2018 - 02/2007
3	Hypertension (High Blood Pressure) 04/2014 - 01/2013
2	Cognitive Dysfunction 10/2021 - 01/2018
2	Myocardial Infarction 02/2021 - 01/2017
2	Inflammation (Inflammations) 01/2021 - 01/2019
2	Pathologic Constriction (Stenosis) 12/2016 - 06/2012
1	Brain Infarction 01/2022
1	Embolic Stroke 01/2022
1	Parkinson Disease (Parkinson's Disease) 10/2021
1	Thromboembolism 01/2021
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2020
1	Abdominal Pain (Pain, Abdominal) 07/2019
1	Pain (Aches) 07/2019
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 07/2019
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019
1	Infections 01/2019
1	Intracranial Thrombosis (Cerebral Thrombosis) 01/2019
1	Lacunar Stroke 01/2019
1	Hematoma 04/2018
1	Cerebral Infarction 01/2018
1	Dementia (Dementias) 01/2018
1	Edema (Dropsy) 05/2016
1	Heart Diseases (Heart Disease) 01/2015
1	Central Nervous System Cavernous Hemangioma 06/2014
1	Leukoencephalopathies 04/2014
1	Diabetes Mellitus 04/2014
1	Body Weight (Weight, Body) 10/2013
1	Neurologic Manifestations (Neurological Manifestations) 05/2013

Drug/Important Bio-Agent (IBA)

26	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022 - 03/2006
12	Biomarkers (Surrogate Marker)IBA 10/2021 - 05/2008
7	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 11/2012
4	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2021 - 11/2010
4	Desmodus rotundus salivary plasminogen activator alpha 1IBA 12/2016 - 02/2009
3	TroponinIBA 02/2021 - 08/2012
3	GadoliniumIBA 01/2019 - 01/2017
3	Contrast MediaIBA 01/2017 - 11/2010
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2014 - 10/2012
3	Pharmaceutical PreparationsIBA 10/2013 - 11/2010
2	C-Reactive ProteinIBA 01/2021 - 11/2012
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2019
2	Biological ProductsIBA 01/2019 - 02/2007
2	Indicators and Reagents (Reagents)IBA 01/2018 - 01/2017
2	Hemoglobins (Hemoglobin)IBA 04/2014 - 11/2012
2	SugarsIBA 01/2014 - 11/2012
1	Factor Xa InhibitorsIBA 01/2022
1	apixabanIBA 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	RivaroxabanIBA 01/2022
1	Vitamin K FDA Link 01/2022
1	ORALIT (ORS)IBA 12/2021
1	4- phenyl- 5,5- dicarbethoxy- 2- pyrrolidinoneIBA 10/2021
1	SmokeIBA 01/2021
1	Vascular Endothelial Growth FactorsIBA 01/2021
1	Matrix Metalloproteinases (MMPs)IBA 01/2021
1	Metalloproteases (Metalloproteinases)IBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	Antidepressive Agents (Antidepressants)IBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2020
1	deoxyhemoglobinIBA 01/2020
1	trans-crotonin (CTN)IBA 01/2019
1	boldenone undecylenate (Equipoise)IBA 01/2019
1	Phenprocoumon (Liquamar)FDA Link 11/2018
1	Troponin T (Troponin T1)IBA 04/2017
1	Glial Fibrillary Acidic ProteinIBA 01/2017
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2017
1	bapineuzumabIBA 05/2016
1	Amyloid (Amyloid Fibrils)IBA 05/2016
1	SteamIBA 01/2016
1	gadobutrolIBA 11/2015
1	danaparoid (Orgaran)FDA Link 01/2015
1	Blood Glucose (Blood Sugar)IBA 01/2015
1	AnticoagulantsIBA 09/2014
1	cyclo(Arg-Pro) (CI 4)IBA 04/2014
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2014
1	Hormones (Hormone)IBA 01/2014
1	Filgrastim (Neupogen)FDA Link 10/2013

Therapy/Procedure

18	Therapeutics 01/2022 - 01/2006
5	Catheter Ablation 01/2022 - 07/2010
3	Length of Stay 02/2021 - 01/2013
2	Secondary Prevention 01/2019 - 01/2013
2	Contraindications 01/2015 - 04/2014
2	Thrombolytic Therapy 06/2013 - 02/2003
2	Aftercare (After-Treatment) 01/2013 - 02/2007
1	Long-Term Care 11/2021
1	Transcatheter Aortic Valve Replacement 01/2021
1	Thrombectomy 01/2021
1	Transcranial Direct Current Stimulation 07/2019
1	Patient Transfer (Patient Dumping) 01/2019
1	Catheters 01/2018
1	Activities of Daily Living (ADL) 01/2018
1	Endovascular Procedures 08/2014
1	Cognitive Training 12/2013